Back
Alpha Teknova
IPOTKNO.NASDAQPast

Alpha Teknova

Biotechnology company

Company website ↗
Foundation year: 1996
Profitability
+46.25%
IPO date
24/06/2021

About

Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. We support customers in the research, clinical, and applied markets with standard catalog offerings and custom GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.

Focusing on agility and customer satisfaction, we strive to meet complex formulation and packaging requirements as well as provide fast turnaround for custom GMP products. As a partner to the biopharma sector, our R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire cell and gene therapy production workflow.


Number of employees

100-250


Headquarters

Hollister, California, United States